Dermatological complications and safety of anti-TNF treatments

被引：71

作者：

Kerbleski, Joseph F. ^{[1
]}

Gottlieb, Alice B. ^{[1
]}

机构：

[1] Tufts Med Ctr, Dept Dermatol, Boston, MA 02111 USA

来源：

GUT | 2009年 / 58卷 / 08期

关键词：

TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; INFUSION REACTIONS; FACTOR-ALPHA; COMBINATION THERAPY; CROHNS-DISEASE; RISK-FACTORS; INFLIXIMAB; INFECTIONS; MANAGEMENT;

D O I：

10.1136/gut.2008.163683

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

It has been reported that tumour necrosis factor (TNF) inhibitors have adverse side-effects including infections, malignancies, demyelinating disease, and induction of autoimmune conditions. Dermatological complications of anti-TNF therapy include injection site reactions, cutaneous infections, allergic rashes, psoriasis, non-melanoma skin cancer (NMSC), and rare reports of lupus-like syndrome, erythema multiforme (EM), Steven's Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN).

引用

页码：1033 / 1039

页数：7

共 50 条

[1] Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease
Mocci, Giammarco
Marzo, Manuela
Papa, Alfredo
Armuzzi, Alessandro
Guidi, Luisa
JOURNAL OF CROHNS & COLITIS, 2013, 7 (10): : 769 - 779
[2] Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
Moran, G. W.
Lim, A. W. K.
Bailey, J. L.
Dubeau, M. -F.
Leung, Y.
Devlin, S. M.
Novak, K.
Kaplan, G. G.
Iacucci, M.
Seow, C.
Martin, L.
Panaccione, R.
Ghosh, S.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (09) : 1002 - 1024
[3] Monitoring of anti-TNF biological treatments
A Ruiz del Agua
D Pascual-Salcedo
A Balsa
I Ramos
L Novalbos
S Ramiro
A Martínez
L Simón
D Nagore
Journal of Translational Medicine, 8 (Suppl 1)
[4] FDA perspective on anti-TNF treatments
Schwieterman, WD
ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 90 - 91
[5] Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn's disease
Hradsky, Ondrej
Kazeka, Denis
Copova, Ivana
Lerchova, Tereza
Mitrova, Katarina
Pospisilova, Kristyna
Sulovcova, Miroslava
Zarubova, Kristyna
Bronsky, Jiri
EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (09) : 3001 - 3008
[6] Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn’s disease
Ondrej Hradsky
Denis Kazeka
Ivana Copova
Tereza Lerchova
Katarina Mitrova
Kristyna Pospisilova
Miroslava Sulovcova
Kristyna Zarubova
Jiri Bronsky
European Journal of Pediatrics, 2021, 180 : 3001 - 3008
[7] Editorial: safety of prenatal exposure to anti-TNF therapy on postnatal infectious complications
Duricova, Dana
Mitrova, Katarina
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (07) : 1216 - 1217
[8] THE SAFETY OF ANTI-TNF AGENTS IN THE ELDERLY
Migliore, A.
Bizzi, E.
Lagana, B.
Altomonte, L.
Zaccari, G.
Granata, M.
Canzoni, M.
Marasini, B.
Massarotti, M.
Massafra, U.
Ranieri, M.
Pilla, R.
Martin, L. S.
Pezza, M.
Vacca, F.
Galluccio, A.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (02) : 415 - 426
[9] Safety of anti-TNF agents in pregnancy
De Felice, Kara M.
Kane, Sunanda
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (03) : 661 - 667
[10] Optimizing anti-TNF treatments in inflammatory bowel disease
Ben-Horin, Shomron
Kopylov, Uri
Chowers, Yehuda
AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 24 - 30

← 1 2 3 4 5 →